238 related articles for article (PubMed ID: 23716599)
1. SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling.
Jordan NV; Prat A; Abell AN; Zawistowski JS; Sciaky N; Karginova OA; Zhou B; Golitz BT; Perou CM; Johnson GL
Mol Cell Biol; 2013 Aug; 33(15):3011-25. PubMed ID: 23716599
[TBL] [Abstract][Full Text] [Related]
2. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
3. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
5. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between Wnt signaling and Phorbol ester-mediated PKC signaling in MCF-7 human breast cancer cells.
Kim S; Chun SY; Kwon YS; Nam KS
Biomed Pharmacother; 2016 Feb; 77():114-9. PubMed ID: 26796274
[TBL] [Abstract][Full Text] [Related]
7. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
[TBL] [Abstract][Full Text] [Related]
8. Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition.
Hong D; Messier TL; Tye CE; Dobson JR; Fritz AJ; Sikora KR; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2017 Mar; 8(11):17610-17627. PubMed ID: 28407681
[TBL] [Abstract][Full Text] [Related]
9. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
[TBL] [Abstract][Full Text] [Related]
10. The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer.
Tropée R; de la Peña Avalos B; Gough M; Snell C; Duijf PHG; Dray E
Breast Cancer Res Treat; 2021 Feb; 185(3):601-614. PubMed ID: 33180234
[TBL] [Abstract][Full Text] [Related]
11. Effect of WNT5A on epithelial-mesenchymal transition and its correlation with tumor invasion and metastasis in nasopharyngeal carcinoma.
Zhu HH; Zhu XY; Zhou MH; Cheng GY; Lou WH
Asian Pac J Trop Med; 2014 Jun; 7(6):488-91. PubMed ID: 25066400
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
Cai J; Guan H; Fang L; Yang Y; Zhu X; Yuan J; Wu J; Li M
J Clin Invest; 2013 Feb; 123(2):566-79. PubMed ID: 23321667
[TBL] [Abstract][Full Text] [Related]
13. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
Ren D; Minami Y; Nishita M
Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370
[TBL] [Abstract][Full Text] [Related]
14. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V
Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122
[TBL] [Abstract][Full Text] [Related]
15. The Trans-Spliced Long Noncoding RNA tsRMST Impedes Human Embryonic Stem Cell Differentiation Through WNT5A-Mediated Inhibition of the Epithelial-to-Mesenchymal Transition.
Yu CY; Kuo HC
Stem Cells; 2016 Aug; 34(8):2052-62. PubMed ID: 27090862
[TBL] [Abstract][Full Text] [Related]
16. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.
Ahmed RA; Alawin OA; Sylvester PW
Cell Prolif; 2016 Aug; 49(4):460-70. PubMed ID: 27323693
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor.
Huguet EL; Smith K; Bicknell R; Harris AL
J Biol Chem; 1995 May; 270(21):12851-6. PubMed ID: 7759542
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]